Durvalumab after sequential CRT safe in stage III, unresectable NSCLC

Durvalumab after sequential CRT safe in stage III, unresectable NSCLC

Presented By

Dr Marina Garassino, University of Chicago, IL, USA

Trial

Phase 2, PACIFIC-6

Conference

ELCC 2022

25 May, 2022 12:37

No impact of grade ≥2 pneumonitis on patient-reported outcomes in PACIFIC

Presented By

Prof. Rina Hui, University of Sydney, Australia

Trial

Phase 3, PACIFIC

Conference

ELCC 2022

25 May, 2022 12:37

5-year PACIFIC data hold strong in NSCLC

Presented By

Dr. Camille Hertzka, AstraZeneca

Trial

Phase 3, PACIFIC

Journal

Physician's Weekly

Conference

ASCO 2021

6 August, 2021 12:05

Overcoming the challenges of immunotherapy in non–small cell lung cancer

Presented By

Dr Sarah B. Goldberg, Dr Melissa Lynne Johnson, Dr Alexander Chi

Trial

PACIFIC, KEYNOTE-024, KEYNOTE-189

Conference

ASCO 2019

15 July, 2019 22:04

Post-discontinuation immunotherapy in PACIFIC

Presented By

Dr Phillip Dennis, Dr Marina Garassino

Trial

Phase 3, PACIFIC

Conference

ELCC 2019

25 June, 2019 23:23

Durvalumab after chemoradiotherapy extends OS in stage 3, unresectable non-small-cell lung cancer

Presented By

Dr Scott Antonia, H. Lee Moffitt Cancer Center and Research Institute, USA

Trial

Phase 3, PACIFIC

Conference

WCLC 2018

21 November, 2018 23:28

Next generation immunotherapy in non-small-cell lung cancer

Presented By

Prof. Solange Peters, Lausanne University Hospital and Ludwig Institute, Switzerland

Conference

WCLC 2018

21 November, 2018 23:02

Interview with the IASCL President, Dr. Giorgio Scagliotti

Expert

Dr. Giorgio Scagliotti, University of Torino, Italy

Conference

WCLC 2018

21 November, 2018 21:24

Medical Conferences

Tag: PACIFIC